Europe closes an agreement to acquire 30 million vaccines from Valneva

The European Commission (EC) has closed negotiations with the French pharmacist Valneva to acquire 30 million vaccines against coronavirus, with the option of acquiring an additional 30 million more.

With this agreement, there are already seven that Europe has closed for the acquisition of different anti-Covid vaccines: Pfizer and BioNTech, Moderna, AstraZeneca, Johnson and Johnson, Sanofi-GSK and Curevac. “Today’s agreement further complements the European Union’s vaccine portfolio and demonstrates the Commission’s commitment to finding a long-term solution to the pandemic,” explained EC President Ursula Von der Leyen.

Last month, the drugmaker announced that it would begin the first clinical trials of its vaccine at four sites in England. According to Reuters, the Phase I and Phase II trials involved 150 volunteers in Bristol, Birmingham, Southampton y Newcastle, and were designed to show if the vaccine is safe and produces an immune response. Through a statement they reported that if they were successful, the company planned to carry out larger trials in April 2021 to determine its effectiveness.

Oxford asks to be validated by the EMA

The pharmaceutical AstraZeneca and the University of Oxford have requested this Tuesday at the European Medicines Agency (EMA) a possible conditional license of use of the Covid-19 vaccine in the European Union, and the EMA could make a decision before January 29.

As confirmed by the agency, its experts in human medicines (CHMP) will analyze the entire data package available in the “shortest possible time” and could issue their conclusions on the possibility that the European Commission grant the conditional license to AstraZeneca at the end of the month.

Moderna arrives in Spain

The First Doses of the Coronavirus Vaccine from the Pharmaceutical Company Moderna, from Belgium, have already arrived in Spain, as confirmed by La Moncloa. Spain will receive some 600,000 doses in six weeks and the first would have already arrived this morning around seven thirty at the central warehouse of the Ministry of Health. From there, they will be distributed to the rest of the territory.

From now on, there will be two anti-Covid vaccines in the State. On the one hand, that developed by Pfizer and BioNTech and now, that of Moderna. The latter has been administered in the United States for days.

Main image: the president of the European Commission, Ursula Von der Leyen / Efe

Did you find this article interesting? To continue guaranteeing committed, courageous and rigorous information, we need your support. Our independence also depends on you.

Subscribe to

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.